Q2 2024 Holdings
Filed 2024-08-13 | 61 holdings | $108.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Health Inc(HROW) | COM | 415858109 | $3.1M | 150,000 | 2.9% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $3.2M | 10,000 | 3.0% |
| Ovintiv Inc(OVV) | COM | 69047Q102 | $3.5M | 74,200 | 3.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.1M | 250,400 | 3.8% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $4.2M | 203,574 | 3.9% |
| Silk Road Medical Inc | COM | 82710M100 | $4.3M | 158,094 | 4.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $5.8M | 42,240 | 5.4% |
| Elutia Inc(ELUT) | COM | 05479K106 | $7.7M | 1,551,655 | 7.1% |
| Biodesix Inc | COM | 09075X108 | $8.5M | 5,541,176 | 7.8% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $28.6M | 688,218 | 26.5% |